Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal Failure

Inclusion Criteria: * Age between 18 and 80 years * Cirrhosis of the liver defined by clinical, biochemical or histological * Functional renal failure with serum creatinine greater than 1.2 mg / dl and less than 2.5 mg / dl. * That, properly informed, give their consent to participate in the study and undergo tests and examinations that entails * Women of childbearing potential: pregnancy test negative serum or urine, and acceptance of use of adequate contraception since at least 14 days prior to the first dose of study drug until 14 days after the last dose Exclusion Criteria: * Pregnant women, nursing mothers, or those who intend to become pregnant during the study period * Systolic blood pressure ≥ 150 mmHg and / or diastolic blood pressure ≥ 90 mmHg * Previous treatment with transjugular intrahepatic portosystemic shunt (TIPS) or surgical portosystemic shunts * Use of antibiotics in the seven days prior to inclusion in the study except for prophylactic (ie. prophylaxis of spontaneous bacterial peritonitis) * Cardiac or respiratory failure * Positive for human immunodeficiency virus * Urinary retention * Ischemic heart disease or peripheral vascular disease. * Narrow Angle Glaucoma * Cerebrovascular occlusions * Aortic Aneurysm * Thyrotoxicosis * Pheochromocytoma